Suparma Tbk PT
IDX:SPMA
Suparma Tbk PT
IDX:SPMA
Price:
300
IDR
-0.66%
Market Closed
Market Cap:
946.2B
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SPMA Alert
Suparma Tbk PT
300
-2 (-0.66%)
| 52 Week Range |
276
390
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Suparma Tbk PT
Balance Sheet
Balance Sheet Decomposition
Suparma Tbk PT
Suparma Tbk PT
| Current Assets | 1.5T |
| Cash & Short-Term Investments | 362.4B |
| Receivables | 200B |
| Other Current Assets | 907B |
| Non-Current Assets | 1.9T |
| Long-Term Investments | 30.6B |
| PP&E | 1.9T |
| Other Non-Current Assets | 15.9B |
| Current Liabilities | 524.8B |
| Accounts Payable | 111.8B |
| Accrued Liabilities | 16.4B |
| Short-Term Debt | 77.8B |
| Other Current Liabilities | 318.8B |
| Non-Current Liabilities | 508B |
| Long-Term Debt | 264.8B |
| Other Non-Current Liabilities | 243.2B |
Balance Sheet
Suparma Tbk PT
Suparma Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
47 926
|
46 259
|
146 961
|
120 543
|
240 382
|
207 415
|
0
|
0
|
0
|
311 956
|
|
| Cash |
47 926
|
46 259
|
146 961
|
120 543
|
240 382
|
207 415
|
0
|
0
|
0
|
311 956
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13 719
|
15 551
|
|
| Total Receivables |
181 436
|
154 527
|
108 133
|
112 111
|
127 405
|
183 127
|
142 605
|
216 491
|
212 205
|
215 524
|
|
| Accounts Receivables |
180 708
|
153 716
|
107 829
|
111 711
|
126 896
|
182 199
|
141 687
|
211 809
|
210 851
|
212 774
|
|
| Other Receivables |
727
|
811
|
304
|
400
|
509
|
927
|
917
|
4 682
|
1 354
|
2 750
|
|
| Inventory |
394 148
|
459 154
|
406 931
|
483 135
|
475 608
|
466 523
|
367 216
|
577 526
|
832 475
|
828 845
|
|
| Other Current Assets |
59 283
|
52 755
|
37 289
|
34 448
|
44 591
|
59 148
|
23 932
|
12 893
|
11 967
|
10 900
|
|
| Total Current Assets |
682 792
|
712 695
|
699 313
|
750 237
|
887 987
|
916 212
|
645 476
|
1 004 401
|
1 370 508
|
1 382 776
|
|
| PP&E Net |
1 389 720
|
1 439 722
|
1 430 165
|
1 393 422
|
1 367 186
|
1 438 908
|
1 659 144
|
1 711 989
|
1 829 176
|
1 874 981
|
|
| PP&E Gross |
1 389 720
|
0
|
0
|
0
|
0
|
1 438 908
|
1 659 144
|
1 711 989
|
1 829 176
|
1 874 981
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1 383 308
|
1 473 131
|
1 564 421
|
1 661 448
|
1 770 214
|
|
| Note Receivable |
14 662
|
14 560
|
22 123
|
22 525
|
18 212
|
7 210
|
0
|
0
|
0
|
15 919
|
|
| Long-Term Investments |
4 551
|
5 256
|
7 251
|
9 477
|
9 461
|
9 802
|
11 445
|
29 764
|
39 547
|
30 247
|
|
| Other Long-Term Assets |
0
|
13 231
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2 091 957
N/A
|
2 185 464
+4%
|
2 158 852
-1%
|
2 175 661
+1%
|
2 282 846
+5%
|
2 372 131
+4%
|
2 316 065
-2%
|
2 746 153
+19%
|
3 239 231
+18%
|
3 303 923
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
38 706
|
36 970
|
47 510
|
62 025
|
75 033
|
78 802
|
103 325
|
104 619
|
132 686
|
94 997
|
|
| Accrued Liabilities |
20 243
|
52 801
|
51 628
|
7 438
|
3 852
|
6 361
|
8 762
|
3 463
|
4 956
|
19 217
|
|
| Short-Term Debt |
117 928
|
103 601
|
127 090
|
130 329
|
128 852
|
20 119
|
83 436
|
67 868
|
32 032
|
36 105
|
|
| Current Portion of Long-Term Debt |
1 840
|
557 369
|
45 129
|
521 074
|
14 876
|
441 987
|
158 512
|
261 610
|
185 827
|
338 173
|
|
| Other Current Liabilities |
8 244
|
15 057
|
12 566
|
12 905
|
13 464
|
18 300
|
18 527
|
13 215
|
19 492
|
3 868
|
|
| Total Current Liabilities |
186 961
|
765 798
|
283 924
|
733 772
|
236 077
|
565 569
|
372 561
|
450 775
|
374 993
|
492 360
|
|
| Long-Term Debt |
1 075 045
|
597 372
|
740 160
|
187 132
|
696 197
|
285 543
|
251 759
|
308 504
|
512 460
|
259 095
|
|
| Deferred Income Tax |
4 114
|
0
|
15 881
|
42 669
|
60 052
|
81 194
|
89 654
|
138 312
|
174 690
|
204 374
|
|
| Other Liabilities |
21 236
|
69 617
|
39 742
|
39 893
|
35 909
|
62 286
|
70 699
|
33 090
|
30 800
|
28 674
|
|
| Total Liabilities |
1 287 357
N/A
|
1 432 787
+11%
|
1 079 706
-25%
|
1 003 466
-7%
|
1 028 236
+2%
|
994 592
-3%
|
784 673
-21%
|
930 680
+19%
|
1 092 943
+17%
|
984 504
-10%
|
|
| Equity | |||||||||||
| Common Stock |
596 819
|
596 819
|
845 828
|
845 828
|
845 828
|
845 828
|
845 828
|
1 116 493
|
1 261 637
|
1 261 637
|
|
| Retained Earnings |
206 748
|
155 414
|
232 500
|
325 004
|
408 017
|
531 132
|
685 100
|
549 634
|
881 407
|
1 055 416
|
|
| Additional Paid In Capital |
598
|
598
|
598
|
598
|
598
|
598
|
598
|
149 464
|
4 320
|
4 320
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
153
|
220
|
765
|
167
|
20
|
134
|
118
|
1 075
|
1 954
|
|
| Total Equity |
804 600
N/A
|
752 677
-6%
|
1 079 147
+43%
|
1 172 195
+9%
|
1 254 610
+7%
|
1 377 539
+10%
|
1 531 392
+11%
|
1 815 473
+19%
|
2 146 288
+18%
|
2 319 419
+8%
|
|
| Total Liabilities & Equity |
2 091 957
N/A
|
2 185 464
+4%
|
2 158 852
-1%
|
2 175 661
+1%
|
2 282 846
+5%
|
2 372 131
+4%
|
2 316 065
-2%
|
2 746 153
+19%
|
3 239 231
+18%
|
3 303 923
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 492
|
1 492
|
3 154
|
3 154
|
3 154
|
3 154
|
3 154
|
3 154
|
3 154
|
3 154
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
